2,3-Dihydrobenzo [1,4] dioxin-2-ylmethyl derivatives as alpha 2C antagonists for use in the treatment of peripheral and central nervous system diseases
Compounds of formula I wherein X, Z, R1-R4, and m are as defined in the claims, exhibit alpha2C antagonistic activity, and are thus useful as alpha2C antagonists. Methods for the treatment of diseases and conditions of the peripheric system and the central nervous system are also disclosed.